Carbohydrate antigen 125: A new biomarker in heart failure

Cardiology in Review

Volumn 21, Issue 1, 2013, Pages 23-26

  Vizzardi, Enrico ^a   D'Aloia, Antonio ^a   Curnis, Antonio ^a   Dei Cas, Livio ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Carbohydrate antigen 125 (CA 125); heart failure; tumor markers

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CA 125 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART FAILURE; CARDIAC PATIENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORRELATIONAL STUDY; HEART FAILURE; HEART LEFT ATRIUM; HEMODYNAMICS; HOSPITAL READMISSION; HUMAN; MORTALITY; PLEURA FLUID; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW;

ACUTE DISEASE; CA-125 ANTIGEN; CHRONIC DISEASE; HEART FAILURE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS;

EID: 84871774098     PISSN: 10615377     EISSN: 15384683     Source Type: Journal    
DOI: 10.1097/CRD.0b013e318265f58f     Document Type: Review

References (32)

1. Nägele H, Bahlo M, Klapdor R, et al. CA 125 and its relation to cardiac function. Am Heart J. 1999;137:1044-1049. (Pubitemid 30040726)
2. D'Aloia A, Faggiano P, Aurigemma G, et al. Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis. J Am Coll Cardiol. 2003;41:1805-1811. (Pubitemid 36584256)
3. Nägele H, Bahlo M, Klapdor R, et al. Fluctuations of tumor markers in heart failure patients pre and post heart transplantation. Anticancer Res. 1999;19(4A):2531-2534. (Pubitemid 29392407)
4. Lavin PT, Knapp RC, Malkasian G, et al. CA 125 for the monitoring of ovarian carcinoma during primary therapy. Obstet Gynecol. 1987;69:223-227. (Pubitemid 17015537)
5. Kenemans P, Yedema CA, Bon GG, et al. CA 125 in gynecological pathology - a review. Eur J Obstet Gynecol Reprod Biol. 1993;49:115-124. (Pubitemid 23233193)
6. van der Burg ME, Lammes FB, Verweij J. CA 125 in ovarian cancer. Neth J Med. 1992;40:36-51.
7. Turk HM, Pekdemir H, Buyukberber S, et al. Serum CA 125 levels in patients with chronic heart failure and accompanying pleural fluid. Tumour Biol. 2003;24:172-175. (Pubitemid 37500565)
8. Kouris NT, Zacharos ID, Kontogianni DD, et al. The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters. Eur J Heart Fail. 2005;7:199-203. (Pubitemid 40215613)
9. Varol E, Ozaydin M, Dogan A, et al. Tumour marker levels in patients with chronic heart failure. Eur J Heart Fail. 2005;7:840-843. (Pubitemid 41125903)
10. Duman C, Ercan E, Tengiz I, et al. Elevated serum CA 125 levels in mitral stenotic patients with heart failure. Cardiology. 2003;100:7-10. (Pubitemid 37140412)
11. Vizzardi E, Nodari S, D'Aloia A, et al. CA 125 tumoral marker plasma levels relate to systolic and diastolic ventricular function and to the clinical status of patients with chronic heart failure. Echocardiography. 2008;25:955-960.
12. Faggiano P, D'Aloia A, Brentana L, et al. Serum levels of different tumour markers in patients with chronic heart failure. Eur J Heart Fail. 2005;7:57-61. (Pubitemid 40092492)
13. Kouris NT, Kontogianni DD, Papoulia EP, et al. Clinical and prognostic value of elevated CA125 levels in patients with congestive heart failure. Hellenic J Cardiol. 2006;47:269-274. (Pubitemid 47621130)
14. Duman D, Palit F, Simsek E, et al. Serum carbohydrate antigen 125 levels in advanced heart failure: relation to B-type natriuretic peptide and left atrial volume. Eur J Heart Fail. 2008;10:556-559.
15. Chen YX, Wang XQ, Fang CF, et al. Value of BNP and tumour marker CA125 in patients with heart failure. Acta Cardiol. 2008;63:501-506.
16. Kosar F, Aksoy Y, Ozguntekin G, et al. Relationship between cytokines and tumour markers in patients with chronic heart failure. Eur J Heart Fail. 2006;8:270-274. (Pubitemid 44275312)
17. Miñana G, Núñez J, Sanchis J, et al. CA125 and immunoinflammatory activity in acute heart failure. Int J Cardiol. 2010;145:547-548.
18. Hamdy NM. Relationship between pro-anti-inflammatory cytokines, T-cell activation and CA 125 in obese patients with heart failure. Med Sci Monit. 2011;17:CR174-CR179.
19. De Gennaro L, Brunetti ND, Montrone D, et al. Inflammatory activation and carbohydrate antigen-125 levels in subjects with atrial fibrillation. Eur J Clin Invest. 2012;42:371-375.
20. Napan S, Aussawapokee T, Nargileci E et al. Prognostic significance of carbohydrate antigen 125 in patients with heart failure and preserved ejection fraction (abstract). J Am Coll Cardiol 2010; 55: A30.
21. Wu YJ, Hung TC, Yeh HI, et al. CA 125 as a novel clinical surrogate for heart failure with preserved ejection fraction and an independent predictor for heart failure hospitalization in women (abstract). Eur Heart J 2011; 32: 10.
22. Yilmaz MB, Zorlu A, Dogan OT, et al. Role of CA-125 in identification of right ventricular failure in chronic obstructive pulmonary disease. Clin Cardiol. 2011;34:244-248.
23. Uz O, Kardesoglu E, Tas D, et al. CA-125 level is associated with right ventricular echocardiographic parameters in patients with COPD. South Med J. 2011;104:624-628.
24. Núñez J, Núñez E, Consuegra L, et al. Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure? Heart. 2007;93:716-721. (Pubitemid 46808274)
25. Núñez J, Sanchis J, Bodí V, et al. Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure. Eur Heart J. 2010;31:1752-1763.
26. Núñez J, Núñez E, Sanchis J, et al. Antigen carbohydrate 125 and brain natriuretic peptide serial measurements for risk stratification following an episode of acute heart failure. Int J Cardiol. 2012;159:21-28.
27. Mansour IN, Napan S, Tarek Alahdab M, et al. Carbohydrate antigen 125 predicts long-term mortality in African American patients with acute decompensated heart failure. Congest Heart Fail. 2010;16:15-20.
28. Yalta K, Yilmaz A, Turgut OO, et al. Evaluation of tumor markers CA-125 and CEA in acute myocardial infarction. Adv Ther. 2006;23:1052-1059. (Pubitemid 46341062)
29. Monteiro S, Franco F, Costa S, et al. Prognostic value of CA125 in advanced heart failure patients. Int J Cardiol. 2010;140:115-118.
30. Vizzardi E, D'Aloia A, Pezzali N, et al. Long-term prognostic value of CA 125 serum levels in mild to moderate heart failure patients. J Card Fail. 2012;18:68-73.
31. De Gennaro L, Brunetti ND, Bungaro R, et al. Carbohydrate antigen-125: additional accuracy in identifying patients at risk of acute heart failure in acute coronary syndrome. Coron Artery Dis. 2009;20:274-280.
32. Filipiak KJ, Folga A, Grabowski M et al. Concomitant estimation of NT-pro-BNP and CA125 for better outcome prognosis in congestive heart failure. Eur J Heart Fail. 2007; 6:22.